Back

Safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation on concomitant treatment with dronedarone

3 April 2022 (08:20 - 20:00)
Organised by:
Congress Presentation Part of: ePosters Day 1 Oral Anticoagulation EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Riccardo Vio

Hospital dell'Angelo, Mestre-Venice (Italy)

128 More presentations in this session

Presentation thumbnail
Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Atrial high-rate episodes in patients with devices without a history of atrial fibrillation
Doctor I. Doundoulakis (Brussels, BE)
Abstract Slides
Presentation thumbnail
The impact of different fat depots in the body on the progression of atrial fibrillation - data from RACE V
Doctor V. Weberndoerfer (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures
Mr T. Kueffer (Bern, CH)
Abstract Slides
Presentation thumbnail
Early mortality and complications following first-time catheter ablation of atrial fibrillation in a nationwide cohort
Doctor C. Witt (Aarhus, DK)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 1

The Event

Event poster

EHRA 2022

3 April 2022 08:20 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con